Patient Education and Motor Control Exercise Among Rural Community-dwelling Adults With Chronic Low Back Pain

August 14, 2021 updated by: Aminu A. Ibrahim, Bayero University Kano, Nigeria

Effects of Patient Education and Motor Control Exercise on Selected Clinical and Psychosocial Variables Among Rural Community-dwelling Adults With Chronic Low Back Pain: a Randomized Clinical Trial

Low back pain (LBP) is the leading cause of years lived with disability globally with increasing concern about its impact in low- and middle-income countries like those situated in Africa where most people are living in rural areas with limited access to health care. Epidemiological studies in Nigeria suggest that the burden of chronic low back pain (CLBP) in rural areas is greater than in urban areas, with both biomechanical and psychological factors being implicated. However, despite the burden of CLBP in rural Nigeria, rehabilitation services are lacking even at the rural primary healthcare centers due to the absence of physiotherapists. Current clinical practice guidelines unanimously recommend education including instruction on self-management options, and exercise as frontline interventions to help individuals with CLBP. However, the specific content of these interventions are rarely described. Patient education (PE) strategies incorporating both biomedical and psychosocial information have been shown to be beneficial for CLBP. Moreover, exercises in the form of motor control exercises (MCEs) have been proven to be effective for CLBP. However, RCTs examining the effects of PE and MCE individually or in combination among rural community-dwelling adults with CLBP are scarce.

The purpose of this study is to determine the effects of PE and MCE program on selected clinical and psychosocial variables among rural community-dwelling adults with nonspecific CLBP.

Study Overview

Detailed Description

Participants will be recruited and assigned to one of three intervention groups that include PE plus MCE group, MCE group, or PE group using a block random technique based on an electronic randomization table generated by a computer software program. Blinded assessment of all outcomes will be performed at baseline, 8 weeks after randomization and at 3, 6 and 12 months follow-up.

Primary outcomes will be functional disability and pain intensity. Secondary outcomes will be quality of life, global perceived recovery, fear-avoidance beliefs, pain catastrophizing, back pain consequences beliefs, and physical performance (finger-floor test, repeated sit-to-stand test, and the 50-foot walk test) Data will be analyzed using descriptive and inferential (mixed-model ANOVA/linear mixed-effects model) statistics. All statistical analyses will be performed on IBM SPSS Statistics ver. 23.0 (IBM Co., Armonk, NY, USA) at alpha level of 0.05.

Study Type

Interventional

Enrollment (Actual)

120

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kano, Nigeria, 700
        • Tsakuwa Primary Healthcare Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Male and female between 16 and 70 years old.
  2. Primary complaint of LBP with or without leg pain experienced at least over the previous 3 months duration.
  3. Mean LBP intensity at least ≥ 3 on numerical rating scale during the past week.
  4. Ability to read/understand English or Hausa language.

Exclusion Criteria:

  1. Previous history of thoracic spine or lumbosacral spine surgery.
  2. Any neurological findings indicating radiculopathy.
  3. Evidence of serious spine pathology (e.g. tumor, infection, fracture, spinal stenosis, inflammatory disease).
  4. Unstable or severe disabling chronic cardiovascular and pulmonary disease.
  5. History of serious psychological or psychiatric illness.
  6. Current pregnancy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Motor Control Exercise and Patient Education

Participants will receive a total of 16 sessions (2 sessions per week) of motor control exercise and 4 sessions (1 session per week) of patient education program as described in respective protocol.

In addition, they will also perform segmental stretching exercises and instructed to perform continuous overground walk as indicated in the control group.

Activation of specific muscles of the lumbopelvic region responsible for providing stability or control of posture and movement.
Other Names:
  • Specific stabilisation exercise
Education aiming to change unhelpful beliefs about LBP, decrease fear avoidance behavior and catastrophic thought, promote positive attitude, self-management, and active coping strategies.
Other Names:
  • Cognitive Education
Experimental: Motor Control Exercise

Participants will receive a total of 16 sessions (2 sessions per week) of motor control exercise aiming at improving function of specific muscles of the lumbopelvic region and the control of posture and movement.

They will also perform segmental stretching exercises and instructed to perform continuous overground walk as indicated in the control group.

Activation of specific muscles of the lumbopelvic region responsible for providing stability or control of posture and movement.
Other Names:
  • Specific stabilisation exercise
Experimental: Patient Education

Participants will receive patient education session once a week at interval of 1-week over 8-weeks (4 sessions). The program will be aiming to provide non-threatening information to enable patients to better understand their pain, change any unhelpful beliefs about LBP, decrease fear avoidance behavior and catastrophic thought, promote positive attitude, self-management, and active coping strategies.

They will also perform segmental stretching exercises and instructed to perform continuous overground walk as indicated in the control group.

Education aiming to change unhelpful beliefs about LBP, decrease fear avoidance behavior and catastrophic thought, promote positive attitude, self-management, and active coping strategies.
Other Names:
  • Cognitive Education

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in functional disability
Time Frame: Baseline, 8 weeks after beginning treatment, and 3, 6 and 12 months follow-up
Functional disability will be measured by Oswestry disability index (ODI). The questionnaire consists of 10 items with each item having six statements. All scores are summed, then multiplied by two to obtain the index (range 0 to 100) with higher score indicating greater disability.
Baseline, 8 weeks after beginning treatment, and 3, 6 and 12 months follow-up
Change in pain Intensity
Time Frame: Baseline, 8 weeks after beginning treatment, and 3, 6 and 12 months follow-up
Pain Intensity will be measured by an 11-point (0-10) Numerical Pain Rating Scale (NPRS), in which 0 represents "no pain" and 10 represents "worst pain imaginable".
Baseline, 8 weeks after beginning treatment, and 3, 6 and 12 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in quality of life
Time Frame: Baseline, 8 weeks after beginning treatment, and 3, 6 and 12 months follow-up
Quality of life will be measured using the SF-12 health survey. The questionnaire consists of 12 items questioned weighted and summed to provide physical and mental health scores (PCS and MCS). The two composite scores are computed using the scores on twelve questions that range from 0 to 100, with higher score indicating better health.
Baseline, 8 weeks after beginning treatment, and 3, 6 and 12 months follow-up
Change in global impression of recovery
Time Frame: Baseline, 8 weeks after beginning treatment, and 3, 6 and 12 months follow-up
Global impression of recovery will be measured by an 11-point Global Perceived Effect Scale (GPES). it range from -5 (vastly worse) to 0 (unchanged) to +5 (completely recovered). Higher scores indicate better recovery.
Baseline, 8 weeks after beginning treatment, and 3, 6 and 12 months follow-up
Change in fear-avoidance beliefs
Time Frame: Baseline, 8 weeks after beginning treatment, and 3-month follow-up
Fear avoidance beliefs will be measured by the fear-avoidance beliefs questionnaire (FABQ). The questionnaire consists of 16 self-response items, rated on a seven-point ordinal scale from 0 to 6. It also contains two subscales, a 7-item subscale concerning work, and a 4-item subscale concerning physical activity. Each subscale scores are summed giving possible ranges for the physical activity subscale of 0-24 and for the work subscale between 0-42. Higher score indicate greater fear and avoidance beliefs.
Baseline, 8 weeks after beginning treatment, and 3-month follow-up
Change in pain catastrophization
Time Frame: Baseline, 8 weeks after beginning treatment, and 3-month follow-up
Pain catastrophizing will be measured by the pain catastrophizing scale (PCS). The scale consists of 13 items rated on 5-point ordinal scale (0-5).The total score ranges from 0-52 with higher score indicating more catastrophic thoughts.
Baseline, 8 weeks after beginning treatment, and 3-month follow-up
Change in back pain consequences beliefs
Time Frame: Baseline, 8 weeks after beginning treatment, and 3-month follow-up
The back pain consequences beliefs will be measured by the Back Beliefs Questionnaire (BBQ). The BBQ is a 14-item scale, with each item rated using a 5-point Likert scale. Nine items (1, 2, 3, 6, 8, 10, 12, 13, and 14) are used for scoring of the questionnaire resulting in a total score ranging from 9-45 with lower scores indicating the more pessimistic beliefs regarding the consequences of back pain.
Baseline, 8 weeks after beginning treatment, and 3-month follow-up
Change in mobility of the spine and pelvis
Time Frame: Baseline and 8 weeks after beginning treatment
The finger-floor distance test (FFD) measures mobility of both the whole spine and the pelvis in the overall motion of bending forward.
Baseline and 8 weeks after beginning treatment
Change in functional performance of sit-to-stand
Time Frame: Baseline and 8 weeks after beginning treatment
The repeated sit-to-stand test measures the time taken to sit-to-stand, five times from a standard chair. The shorter the time taken to complete the test, the better the performance.
Baseline and 8 weeks after beginning treatment
Change in functional performance of 50-foot walk
Time Frame: Baseline and 8 weeks after beginning treatment
The 50-foot walk test measures time taken to walk a distance of 50-foot. The shorter the time taken to complete the test, the better the performance.
Baseline and 8 weeks after beginning treatment

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Aminu A. Ibrahim, Physiotherapy Department, Faculty of Allied Health Sciences, College of Health Sciences, Bayero University, Kano. Nigeria

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 3, 2018

Primary Completion (Actual)

October 1, 2019

Study Completion (Actual)

January 6, 2020

Study Registration Dates

First Submitted

December 6, 2017

First Submitted That Met QC Criteria

January 5, 2018

First Posted (Actual)

January 8, 2018

Study Record Updates

Last Update Posted (Actual)

August 20, 2021

Last Update Submitted That Met QC Criteria

August 14, 2021

Last Verified

August 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • SPS/15/PPT/00009

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Nonspecific Chronic Low Back Pain

Clinical Trials on Motor Control Exercise

3
Subscribe